Local News BBI Faculty Conversations: Dr. Heather Gustafson Brotman Baty Institute | November 2, 2021 During this BBI Faculty Conversations, they are joined by BBI member Dr. Heather Gustafson, Assistant…dcorriganNovember 2, 2021 Read More
Publications of the Week Metabolic Regulation by PD-1 Signaling Promotes Long-Lived Quiescent CD8 T Cell Memory in Mice Kalia, V., et al. | November 1, 2021 Inhibitory signaling in dysfunctional CD8 T cells through the programmed cell death 1 (PD-1) axis…dcorriganNovember 1, 2021 Read More
Awards Dr. Holland Receives NCI Outstanding Investigator Award Fred Hutch | November 1, 2021 Fred Hutchinson Cancer Research Center neuroscientist Dr. Eric Holland has received a National Cancer Institute Outstanding Investigator Award.…dcorriganNovember 1, 2021 Read More
Local News DOD Funds $4.3M Human Trial on Device to Enhance Sleep UW Medicine | October 29, 2021 The U.S. Department of Defense is funding the first human trial of a device to…dcorriganOctober 29, 2021 Read More
Publications of the Week Transcriptional and Functional Divergence in Lateral Hypothalamic Glutamate Neurons Projecting to the Lateral Habenula and Ventral Tegmental Area Neuron | October 29, 2021 The lateral hypothalamic area (LHA) regulates feeding- and reward-related behavior, but because of its molecular…dcorriganOctober 29, 2021 Read More
Publications of the Week The Novel Anti-CRISPR AcrIIA22 Relieves DNA Torsion in Target Plasmids and Impairs SpyCas9 Activity Forsberg, K. J., et al. | October 28, 2021 To overcome CRISPR-Cas defense systems, many phages and mobile genetic elements (MGEs) encode CRISPR-Cas inhibitors…dcorriganOctober 28, 2021 Read More
Local News Athira Pharma Announces Completion of Enrollment in Phase II ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer’s Disease Athira Pharma | October 28, 2021 Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore…dcorriganOctober 28, 2021 Read More
Local News Mozart Therapeutics Launches with $55 Million Series a Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases Mozart Therapeutics | October 28, 2021 Mozart Therapeutics, Inc., a new biopharmaceutical company targeting a novel immune pathway to change the…dcorriganOctober 28, 2021 Read More
Local News Looking Back and Projecting Ahead as AVE Celebrates One Year Brotman Baty Institute | October 27, 2021 This October marks the one-year anniversary of the Atlas of Variant Effects (AVE) Alliance. AVE…dcorriganOctober 27, 2021 Read More
Local News How Pandemic-Driven Talent Migration Will Change Where Biotech Companies Are Located GeekWire | October 27, 2021 Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman…dcorriganOctober 27, 2021 Read More